These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11306774)

  • 1. Amantadine increases gait steadiness in frontal gait disorder due to subcortical vascular encephalopathy: a double-blind randomized placebo-controlled trial based on quantitative gait analysis.
    Baezner H; Oster M; Henning O; Cohen S; Hennerici MG
    Cerebrovasc Dis; 2001; 11(3):235-44. PubMed ID: 11306774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of gait in subcortical vascular encephalopathy by computerized analysis: a cross-sectional and longitudinal study.
    Bäzner H; Oster M; Daffertshofer M; Hennerici M
    J Neurol; 2000 Nov; 247(11):841-9. PubMed ID: 11151415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trial.
    Lee JY; Oh S; Kim JM; Kim JS; Oh E; Kim HT; Jeon BS; Cho JW
    J Neurol; 2013 Dec; 260(12):3030-8. PubMed ID: 24057149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subcortical vascular encephalopathy].
    Baezner H; Daffertshofer M
    Ther Umsch; 2003 Sep; 60(9):541-52. PubMed ID: 14579623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and Parkinsonism.
    McGarry A; Biglan K
    Parkinsonism Relat Disord; 2013 Jun; 19(6):643-4. PubMed ID: 23561947
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial.
    Kim YE; Yun JY; Yang HJ; Kim HJ; Gu N; Yoon SH; Cho JY; Jeon BS
    PLoS One; 2012; 7(11):e48890. PubMed ID: 23185280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine improves gait in PD patients with STN stimulation.
    Chan HF; Kukkle PL; Merello M; Lim SY; Poon YY; Moro E
    Parkinsonism Relat Disord; 2013 Mar; 19(3):316-9. PubMed ID: 23218842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled trial of amantadine in multiple-system atrophy.
    Wenning GK;
    Clin Neuropharmacol; 2005; 28(5):225-7. PubMed ID: 16239762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
    Gironell A; Kulisevsky J; Pascual-Sedano B; Flamarich D
    Mov Disord; 2006 Apr; 21(4):441-5. PubMed ID: 16229019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial.
    Bassez G; Audureau E; Hogrel JY; Arrouasse R; Baghdoyan S; Bhugaloo H; Gourlay-Chu ML; Le Corvoisier P; Peschanski M
    Brain; 2018 Oct; 141(10):2855-2865. PubMed ID: 30169600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).
    Pahwa R; Tanner CM; Hauser RA; Sethi K; Isaacson S; Truong D; Struck L; Ruby AE; McClure NL; Went GT; Stempien MJ
    Mov Disord; 2015 May; 30(6):788-95. PubMed ID: 25650051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult.
    Devine MF; Herrin C; Warnack W; Dubey D
    J Postgrad Med; 2018; 64(1):53-55. PubMed ID: 28862245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
    Ory-Magne F; Corvol JC; Azulay JP; Bonnet AM; Brefel-Courbon C; Damier P; Dellapina E; Destée A; Durif F; Galitzky M; Lebouvier T; Meissner W; Thalamas C; Tison F; Salis A; Sommet A; Viallet F; Vidailhet M; Rascol O;
    Neurology; 2014 Jan; 82(4):300-7. PubMed ID: 24371304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.
    Helbling B; Stamenic I; Viani F; Gonvers JJ; Dufour JF; Reichen J; Cathomas G; Steuerwald M; Borovicka J; Sagmeister M; Renner EL;
    Hepatology; 2002 Feb; 35(2):447-54. PubMed ID: 11826422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.
    Al-Shorafat DM; Lang AE
    Can J Neurol Sci; 2019 Nov; 46(6):782-784. PubMed ID: 31366412
    [No Abstract]   [Full Text] [Related]  

  • 18. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
    da Silva-Júnior FP; Braga-Neto P; Sueli Monte F; de Bruin VM
    Parkinsonism Relat Disord; 2005 Nov; 11(7):449-52. PubMed ID: 16154788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of early administration of the N-methyl-d-aspartate receptor antagonist amantadine on the development of postmastectomy pain syndrome: a prospective pilot study.
    Eisenberg E; Pud D; Koltun L; Loven D
    J Pain; 2007 Mar; 8(3):223-9. PubMed ID: 16996315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.